Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment
Simone Beretta, Anna Coppo, Elisa Bianchi, Clara Zanchi, Davide Carone, Andrea Stabile, Giada Padovano, Endrit Sulmina, Alice Grassi, Graziella Bogliun, Giuseppe Foti, Carlo Ferrarese, Antonio Pesenti, Ettore Beghi, Leonello Avalli, Simone Beretta, Anna Coppo, Elisa Bianchi, Clara Zanchi, Davide Carone, Andrea Stabile, Giada Padovano, Endrit Sulmina, Alice Grassi, Graziella Bogliun, Giuseppe Foti, Carlo Ferrarese, Antonio Pesenti, Ettore Beghi, Leonello Avalli
Abstract
Objective: To investigate neurologic outcome of patients with cardiac arrest with refractory status epilepticus (RSE) treated with a standardized aggressive protocol with antiepileptic drugs and anesthetics compared to patients with other EEG patterns.
Methods: In the prospective cohort study, 166 consecutive patients with cardiac arrest in coma were stratified according to 4 independent EEG patterns (benign, RSE, generalized periodic discharges [GPDs], malignant nonepileptiform) and multimodal prognostic indicators. Primary outcomes were survival and cerebral performance category (CPC) at 6 months.
Results: RSE occurred in 36 patients (21.7%) and was treated with an aggressive standardized protocol as long as multimodal prognostic indicators were not unfavorable. RSE started after 3 ± 2.3 days after cardiac arrest and lasted 4.7 ± 4.3 days. A benign EEG pattern was recorded in 76 patients (45.8%); a periodic pattern (GPDs) was seen in 13 patients (7.8%); and a malignant nonepileptiform EEG pattern was recorded in 41 patients (24.7%). The 4 EEG patterns were highly associated with different prognostic indicators (low-flow time, clinical motor seizures, N20 responses, neuron-specific enolase, neuroimaging). Survival and good neurologic outcome (CPC 1 or 2) at 6 months were 72.4% and 71.1% for benign EEG pattern, 54.3% and 44.4% for RSE, 15.4% and 0% for GPDs, and 2.4% and 0% for malignant nonepileptiform EEG pattern, respectively.
Conclusions: Aggressive and prolonged treatment of RSE may be justified in patients with cardiac arrest with favorable multimodal prognostic indicators.
© 2018 American Academy of Neurology.
Source: PubMed